RAMM Pharma Corp. (RAMM.CN)

0.0600 0.0000 (0.00%) As of 01:11PM EDT. Market open.

RAMM Pharma Corp.

200, 82 Richmond St. East
Toronto, ON M5C 1P1
Canada
416-848-7744

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jackie Peter Burnett	President, CEO & Chairman	676.98k	N/A	N/A
Mr. Guillermo Martin Delmonte	COO, Interim CFO & Corporate Secretary (Leave of Absence)	370.75k	N/A	N/A
Mr. Jose Roldan	Interim CFO	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland. The company also engages in the resale of medical supplies products; and sale of medical devices and consumables, and veterinarian products. It offers Cosmetic CBD+CBG. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.

Corporate Governance

RAMM Pharma Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.